Literature DB >> 21965470

Is the recall of men who have sex with men (MSM) diagnosed as having bacterial sexually transmitted infections (STIs) for re-screening a feasible and effective strategy?

Derval Harte1, Danielle Mercey, Jay Jarman, Paul Benn.   

Abstract

OBJECTIVES: To assess the feasibility and outcomes of recalling men who have sex with men (MSM) diagnosed as having a bacterial sexually transmitted infection (STI) for re-screening.
METHODS: This evaluation was conducted from December 2008 for a 9-month period. MSM diagnosed as having a bacterial STI in that period were offered recall for re-screening 3 months after their diagnosis. Re-screening rates and infection incidence were calculated. Differences in baseline characteristics by re-screening status and factors predictive of infection at re-screening were assessed using the Mann-Whitney test, χ(2) test and logistic regression.
RESULTS: Of the 337 MSM diagnosed as having a bacterial STI, 301 were offered recall. Of these, 206 (68.4%) re-screened after 3 months, 30 (10%) declined and the remainder did not re-attend despite giving verbal consent. Compared with those not re-screening, those re-screening were less likely to be HIV positive (p=0.001), but there was no difference in baseline risk behaviours. There were 15 diagnoses of bacterial STIs at re-screening (29 per 100 person-year follow-up (pyfu); 95% CI 14.3 to 43.7) and five new HIV diagnoses of whom three had a negative test at baseline, one tested negative 6 months earlier and one never tested. Among those testing at both time points, the HIV incidence was 8.3 per 100 pyfu (95% CI 0.0 to 17.7).
CONCLUSIONS: This evaluation demonstrates a 'recall for re-screening' strategy is feasible in terms of high re-screening rates and incidence of new infections diagnosed. Experimental evidence is needed to assess cost-effectiveness and whether it achieves its aim of reducing transmission of STIs and HIV.

Entities:  

Mesh:

Year:  2011        PMID: 21965470     DOI: 10.1136/sextrans-2011-050144

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests.

Authors:  Kirsty S Smith; Jane S Hocking; Marcus Chen; Christopher K Fairley; Anna McNulty; Phillip Read; Catriona S Bradshaw; Sepehr N Tabrizi; Handan Wand; Marion Saville; William Rawlinson; Suzanne M Garland; Basil Donovan; John M Kaldor; Rebecca Guy
Journal:  BMC Infect Dis       Date:  2014-04-24       Impact factor: 3.090

2.  Association between knowledge, risk behaviours, and testing for sexually transmitted infections among men who have sex with men: findings from a large online survey in the United Kingdom.

Authors:  S Wayal; D Reid; P Weatherburn; P Blomquist; S Fabiane; G Hughes; C H Mercer
Journal:  HIV Med       Date:  2019-05-24       Impact factor: 3.180

Review 3.  The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review.

Authors:  Palmo Brunner; Karma Brunner; Daniel Kübler
Journal:  AIDS Behav       Date:  2022-01-15

4.  Sexually transmitted infection testing and self-reported diagnoses among a community sample of men who have sex with men, in Scotland.

Authors:  Lisa M McDaid; Jessica Li; Christina Knussen; Paul Flowers
Journal:  Sex Transm Infect       Date:  2012-10-05       Impact factor: 3.519

5.  The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial.

Authors:  K S Smith; J M Kaldor; J S Hocking; M S Jamil; A M McNulty; P Read; C S Bradshaw; M Y Chen; C K Fairley; H Wand; K Worthington; S Blake; V Knight; W Rawlinson; M Saville; S N Tabrizi; S M Garland; B Donovan; R Guy
Journal:  BMC Public Health       Date:  2016-01-28       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.